Carrousel 1


The Mitochondrial Medicine Company

Khondrion is a biopharmaceutical company focusing on the discovery and development of innovative drugs to treat mitochondrial disease


About Khondrion About Mitochondrial Disease

carrousel 2

In-depth understanding of mitochondrial disease

Khondrion lies on extensive knowledge of mitochondrial disease and a proprietary innovative technology platform


More about R&D

Carrousel 3

Khondrion receives

Orphan Drug Designation

Khondrion has received an Orphan Drug Designation from the European Commission of its frontrunner compound KH176, for the treatment of Leigh syndrome and MELAS syndrome.

More news

Company header test 1 1440x360.png

About Khondrion

R&D header 1440x360.png

Research & Development

News header 1440x360.png



Contact us header.png

Contact us

Submit your question

Contact us

Khondrion BV

Phone: +31 24 361 06 39

Postal address

PO BOX 9101
6500 HB Nijmegen
The Netherlands

Visiting address

Philips van Leydenlaan 15 (west entrance)
6525 EX Nijmegen
The Netherlands
Internal route number 427 

To top